-
EP4359800
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4359800
| EP4359800 - PREDICTING CANCER RELAPSE [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 29.03.2024 Database last updated on 15.06.2024 | |
| Former | The international publication has been made Status updated on 30.12.2022 | Most recent event Tooltip | 14.05.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states AroCell AB Karlsbodavägen 39 168 67 Bromma / SE | [2024/18] | Inventor(s) | 01 /
ERIKSSON, Staffan 181 46 Lidingö / SE | 02 /
VENGE, Per 753 12 Uppsala / SE | [2024/18] | Representative(s) | Barker Brettell Sweden AB Östermalmsgatan 87B 114 59 Stockholm / SE | [2024/18] | Application number, filing date | 22828869.2 | 21.06.2022 | [2024/18] | WO2022SE50614 | Priority number, date | US202163213791P | 23.06.2021 Original published format: US 202163213791 P | [2024/18] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022271069 | Date: | 29.12.2022 | Language: | EN | [2022/52] | Type: | A1 Application with search report | No.: | EP4359800 | Date: | 01.05.2024 | Language: | EN | The application published by WIPO in one of the EPO official languages on 29.12.2022 takes the place of the publication of the European patent application. | [2024/18] | Search report(s) | International search report - published on: | SE | 29.12.2022 | Classification | IPC: | G01N33/574, C12Q1/25, C12N9/12 | [2024/18] | CPC: |
G01N33/57426 (EP);
C07K16/40 (EP);
C12N9/1211 (EP);
G01N33/573 (EP);
G01N33/57407 (EP);
C07K2317/34 (EP);
G01N2800/54 (EP)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2024/18] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | VORHERSAGE EINES KREBSREZIDIVS | [2024/18] | English: | PREDICTING CANCER RELAPSE | [2024/18] | French: | PRÉDICTION DE RECHUTE DE CANCER | [2024/18] | Entry into regional phase | 10.11.2023 | National basic fee paid | 10.11.2023 | Search fee paid | 10.11.2023 | Designation fee(s) paid | 10.11.2023 | Examination fee paid | Examination procedure | 10.11.2023 | Amendment by applicant (claims and/or description) | 10.11.2023 | Examination requested [2024/18] | Fees paid | Renewal fee | 14.05.2024 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]US2008187909 (DAI HONGYUE [US], et al) [A] 1-23* ; See paragraphs [0002], [0075], [0079], [0224] and table 3, page 16, SEQ ID: 115 *; | [YA]WO2015094106 (AROCELL AB [SE]) [Y] 15-21 * ; See claims 5 - 11 and page 1, lines 17 - 22 * [A] 1-14, 22-23; | [DA]WO2019201901 (HOFFMANN LA ROCHE [CH], et al) [DA] 1-23 * ; See the whole document *; | [XY]WO2020043868 (HOFFMANN LA ROCHE [CH], et al) [X] 1-14, 22-23 * ; See page 4, lines 3 - 8; page 5, lines 24 - 28; page 7, lines 3 - 13; page 13, lines 3, 12 - 29; page 19, lines 8 - 14; page 25, lines 26 - 30; page 41, lines 9 - 10; page 43, lines 1 - 6; page 50, lines 12 - 13; claims 1, 6, 9; examples 2 and 5 * [Y] 15-21 |